openPR Logo
Press release

Vaccine Management Solution Market Is Expected To Progress At A CAGR Of 11.9% by 2032

11-27-2023 11:46 AM CET | Health & Medicine

Press release from: Fact.MR

Vaccine Management Solution Market Is Expected To Progress At

The vaccine management solution market has emerged as a crucial player in the global healthcare landscape, gaining substantial attention in the wake of the COVID-19 pandemic. With the imperative need for efficient vaccine distribution, inventory management, and tracking, vaccine management solutions have proven their worth. In this comprehensive overview, we will explore the current state of the vaccine management solution market, key factors driving its growth, and recent industry news that highlights the role these solutions play in enhancing public health and immunization efforts.

The global vaccine management solution market has reached a valuation of US$ 233 million in 2022 and is expected to progress at a CAGR of 11.9% to reach US$ 721 million by the end of 2032. Deployment of vaccine management solutions accounted for less than 2% share of the global pharmacy management market at the end of 2021. A major driver of the vaccine management solution market expansion is the commitment that numerous countries have made to the Global Vaccine Action Plan (GVAP). The use of a centralized system and a vaccine management solution is likely to aid providers in managing workflow more successfully.

๐——๐—ผ๐˜„๐—ป๐—น๐—ผ๐—ฎ๐—ฑ ๐—ฎ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—–๐—ผ๐—ฝ๐˜† ๐—ผ๐—ณ ๐—ง๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:
https://www.factmr.com/connectus/sample?flag=S&rep_id=5466

๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ

The global vaccine management solution market has undergone a significant transformation in recent years, primarily catalyzed by the urgency to distribute COVID-19 vaccines worldwide. As of my last knowledge update in September 2021, this market was valued at approximately $280 million. However, it is important to note that the dynamics of the vaccine management solution market have evolved since then, given the rapid developments in vaccine distribution and administration.

๐—ž๐—ฒ๐˜† ๐—™๐—ฎ๐—ฐ๐˜๐—ผ๐—ฟ๐˜€ ๐——๐—ฟ๐—ถ๐˜ƒ๐—ถ๐—ป๐—ด ๐—š๐—ฟ๐—ผ๐˜„๐˜๐—ต

COVID-19 Pandemic: The COVID-19 pandemic has been a primary driver for the vaccine management solution market. The urgency to vaccinate billions of people globally has accelerated the adoption of these solutions, from tracking vaccine distribution to ensuring equitable access.

Immunization Programs: Immunization campaigns against various diseases are a key driver for vaccine management solutions. Governments and healthcare organizations are increasingly relying on these tools to streamline the logistics of vaccine distribution and record-keeping.

Inventory Management: Vaccine management solutions assist in monitoring vaccine inventories, reducing wastage, and ensuring vaccines are stored and distributed within the recommended temperature range, a critical factor in maintaining vaccine efficacy.

Data Security: The need for secure and compliant data storage and sharing has become paramount, given the sensitive nature of vaccine administration data. Vaccine management solutions are instrumental in maintaining data privacy and integrity.

Telehealth and Remote Vaccination: The advent of telehealth and remote vaccination services has prompted the need for digital tools that can seamlessly integrate with these services. Vaccine management solutions are evolving to accommodate these changing healthcare delivery models.

๐—ฆ๐—ผ๐—บ๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ธ๐—ฒ๐˜† ๐—ฑ๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—ฎ๐—ฟ๐—ฒ :

In 2020, Omnisys announced launching OmniLINK vaccine management solution (VMS) that particularly focuses on pharmacy-administered immunization programs.

In February 2020, Infosys, an Indian multinational information technology company, announced acquiring a Utah-based company named Simplus for US$ 250 million. The acquisition assists the company in providing vaccine management solutions.

๐—ž๐—ฒ๐˜† ๐—–๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€ ๐—ฃ๐—ฟ๐—ผ๐—ณ๐—ถ๐—น๐—ฒ๐—ฑ

Infosys
Deloitte
Salesforce
Conduent
UL LLC
Sense Corp
Qualtrics
Omnisys
Promero
PreCheck
Epazz
Mazik Global
HealthRX

๐—ฅ๐—ฒ๐—ฐ๐—ฒ๐—ป๐˜ ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—ก๐—ฒ๐˜„๐˜€

As of my last knowledge update, here are some significant developments in the vaccine management solution market:

Global Vaccination Campaigns: The deployment of COVID-19 vaccines on a global scale has been a remarkable feat, with vaccine management solutions at the core of the effort. This has brought to light the importance of these solutions in ensuring the equitable distribution of vaccines and tracking of immunization progress.

Digital Vaccine Passports: Many countries have introduced digital vaccine passports or certificates to facilitate international travel. Vaccine management solutions play a pivotal role in generating and verifying these digital documents.

Integration with EHRs: Integration between vaccine management solutions and electronic health records (EHRs) is becoming more seamless. This enables healthcare providers to access a patient's vaccination history and administer vaccines more effectively.

Blockchain for Vaccine Tracking: Blockchain technology is being explored for vaccine tracking and supply chain management. The immutable nature of blockchain ensures the transparency and traceability of vaccine distribution.

Vaccine Mandates: In response to the COVID-19 pandemic, several governments and organizations have introduced vaccine mandates. Vaccine management solutions are essential for tracking and verifying compliance with these mandates.

Supply Chain Resilience: The vaccine management solution market has brought attention to the need for resilient and agile supply chains in healthcare. The ability to respond quickly to disruptions and ensure the continuous flow of vaccines is crucial.

Pharmaceutical Partnerships: Collaboration between vaccine management solution providers and pharmaceutical companies has become more prevalent. This fosters innovation in vaccine management technology and ensures seamless integration with vaccine manufacturers' systems.

๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐—ฉ๐—ฎ๐—ฐ๐—ฐ๐—ถ๐—ป๐—ฒ ๐— ๐—ฎ๐—ป๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—ฆ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜†

๐—•๐˜† ๐—–๐—ผ๐—บ๐—ฝ๐—ผ๐—ป๐—ฒ๐—ป๐˜ :
Solutions
Inventory Management
Program Management
Clinical V. Management
Data Management
Public Engagement
Organizational Support
Services
Managed Services
Professional Services

๐—•๐˜† ๐— ๐—ผ๐—ฑ๐—ฒ๐—น :
Platform Solutions
One Point Solutions

๐—•๐˜† ๐—ฆ๐˜‚๐—ฏ๐˜€๐—ฐ๐—ฟ๐—ถ๐—ฝ๐˜๐—ถ๐—ผ๐—ป :
New Subscribers
Renew Subscribers

๐—•๐˜† ๐—˜๐—ป๐—ฑ-๐—จ๐˜€๐—ฒ :
Public
Private

๐—•๐˜† ๐—ฅ๐—ฒ๐—ด๐—ถ๐—ผ๐—ป :
North America
Latin America
Europe
East Asia
South Asia & Oceania
Middle East & Africa

๐—š๐—ฒ๐˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ป ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฆ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=5466

๐—˜๐—ป๐—ต๐—ฎ๐—ป๐—ฐ๐—ถ๐—ป๐—ด ๐—œ๐—บ๐—บ๐˜‚๐—ป๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—˜๐—ณ๐—ณ๐—ผ๐—ฟ๐˜๐˜€

Vaccine management solutions have proven to be indispensable tools in public health initiatives. From streamlining vaccine distribution to enabling accurate record-keeping, these solutions are the linchpin in global immunization campaigns. The COVID-19 pandemic has underscored their importance, but their value extends beyond this crisis to routine immunization programs.

One of the key areas of innovation is the development of digital vaccine passports or certificates. These documents are essential for verifying an individual's vaccination status, facilitating travel, and gaining access to public venues. Vaccine management solutions are at the forefront of generating and verifying these digital certificates, ensuring their integrity and security.

Additionally, the integration of vaccine management solutions with electronic health records has made vaccine administration more efficient. Healthcare providers can quickly access a patient's vaccination history, make informed decisions, and ensure that individuals are up to date with their immunizations.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaccine Management Solution Market Is Expected To Progress At A CAGR Of 11.9% by 2032 here

News-ID: 3304563 • Views: โ€ฆ

More Releases from Fact.MR

Blockchain in Telecom Market to Surge from USD 795.8 Million in 2025 to USD 211,942.6 Million by 2035
Blockchain in Telecom Market to Surge from USD 795.8 Million in 2025 to USD 211, โ€ฆ
The global blockchain in telecom market is making significant strides as telecom operators, infrastructure providers, and technology vendors increasingly turn to decentralized ledger technologies to address challenges such as fraud, identity verification, and transparency. According to the latest Fact.MR analysis, the market is valued at USD 795.8 million in 2025, illustrating how blockchain is no longer a fringe concept but a growing core component in telecom strategies. Telecom companies areโ€ฆ
Translation Software Market Growing at around 6.5% CAGR (2025-2035)
Translation Software Market Growing at around 6.5% CAGR (2025-2035)
The translation software market has reached an estimated value of USD 10.7 billion in 2025, as globalization intensifies and digital content proliferates across industries. Businesses are increasingly publishing content in multiple languages to capture international markets, comply with regulations, and improve customer experience. Advances in artificial intelligence, especially neural machine translation models, are enhancing accuracy and reducing time lag, making software translation a more viable alternative to human translation forโ€ฆ
Sterility Indicators Market Valued at USD 1.37 Billion in 2025 | Fact.MR Analysis
09-12-2025 | Health & Medicine
Fact.MR
Sterility Indicators Market Valued at USD 1.37 Billion in 2025 | Fact.MR Analysi โ€ฆ
The global sterility indicators market has firmly established its importance by 2025, reaching an estimated valuation of USD 1.37 billion. This growth reflects increasing global emphasis on infection prevention, sterilization validation, and quality compliance in healthcare, pharmaceutical, and medical device manufacturing sectors. Hospitals, clinics, and labs are demanding both biological and chemical indicators to ensure that sterilization processes-whether via steam, heat, radiation, or chemical agents-meet the required safety and regulatoryโ€ฆ
Antibody Fragments Market is Growing at a CAGR of 6.2% by 2035 | Key Players: Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Amgen Inc., Bristol-Myers Squibb Company
09-12-2025 | Health & Medicine
Fact.MR
Antibody Fragments Market is Growing at a CAGR of 6.2% by 2035 | Key Players: No โ€ฆ
The global antibody fragments market has firmly established its importance in biopharmaceuticals and diagnostics by 2024, achieving a valuation of approximately USD 8,563 million. Growth to this level has been driven by increasing incidence of chronic and immunological disorders, rising demand for more precise and targeted therapies, and improvements in biologic technologies. Antibody fragments, which include Fab, scFv, sdAb and other smaller binding modules, are finding favor due to theirโ€ฆ

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at ย https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: ย AstraZeneca ย Bharat Biotech ย Dynavax Technologies Corporation ย GlaxoSmithKline ย Johnson & Johnson ย Merck and Co ย Novartis ย Pfizer ย Sanofi Pasteur ย Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusingโ€ฆ
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the โ€œUnivers โ€ฆ
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, marketโ€ฆ
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, topโ€ฆ
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on โ€œInfluenza Vaccines in the United States โ€“ Market Size, Trends, Opportunities and Growth Potentialโ€ delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyzeโ€ฆ
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by theโ€ฆ
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled โ€œPaediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 โ€“ 2026โ€, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportionโ€ฆ